Deisenhammer F - Search Results

1

Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.

Wanschitz JV, Kaml M, Pfausler B, Helbok R, Wildner S, Widmann G, Sahanic S, Deisenhammer F, Löscher WN, Reindl M, Löffler-Ragg J, Beer R. Wanschitz JV, et al. Among authors: deisenhammer f. J Neurol. 2021 Aug;268(8):2700-2702. doi: 10.1007/s00415-020-10310-x. Epub 2020 Nov 20. J Neurol. 2021. PMID: 33216224 Free PMC article. No abstract available.

2

Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients.

Deisenhammer F, Keir G, Pfausler B, Thompson EJ. Deisenhammer F, et al. J Neuroimmunol. 1996 May;66(1-2):85-93. doi: 10.1016/0165-5728(96)00029-x. J Neuroimmunol. 1996. PMID: 8964918

3

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies.

Deisenhammer F, Reindl M, Harvey J, Gasse T, Dilitz E, Berger T. Deisenhammer F, et al. Neurology. 1999 Apr 12;52(6):1239-43. doi: 10.1212/wnl.52.6.1239. Neurology. 1999. PMID: 10214750

4

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T. Reindl M, et al. Among authors: deisenhammer f. Brain. 1999 Nov;122 ( Pt 11):2047-56. doi: 10.1093/brain/122.11.2047. Brain. 1999. PMID: 10545390 Clinical Trial.

5

A comparative study of the relative bioavailability of different interferon beta preparations.

Deisenhammer F, Mayringer I, Harvey J, Dilitz E, Gasse T, Stadlbauer D, Reindl M, Berger T. Deisenhammer F, et al. Neurology. 2000 Jun 13;54(11):2055-60. doi: 10.1212/wnl.54.11.2055. Neurology. 2000. PMID: 10851362 Clinical Trial.

6

Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against IFN-beta1b.

Deisenhammer F, Reindl M, Berger T. Deisenhammer F, et al. J Interferon Cytokine Res. 2001 Mar;21(3):167-71. doi: 10.1089/107999001750133195. J Interferon Cytokine Res. 2001. PMID: 11331039

7

Increased intrathecal production of apolipoprotein D in multiple sclerosis.

Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, Berger T. Reindl M, et al. Among authors: deisenhammer f. J Neuroimmunol. 2001 Oct 1;119(2):327-32. doi: 10.1016/s0165-5728(01)00378-2. J Neuroimmunol. 2001. PMID: 11585636

8

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.

Egg R, Reindl M, Deisenhammer F, Linington C, Berger T. Egg R, et al. Among authors: deisenhammer f. Mult Scler. 2001 Oct;7(5):285-9. doi: 10.1177/135245850100700503. Mult Scler. 2001. PMID: 11724443

9

Non convulsive status epilepticus after replacement of valproate with lamotrigine.

Trinka E, Dilitz E, Unterberger I, Luef G, Deisenhammer F, Niedermüller U, Thaler C, Bauer G. Trinka E, et al. Among authors: deisenhammer f. J Neurol. 2002 Oct;249(10):1417-22. doi: 10.1007/s00415-002-0857-3. J Neurol. 2002. PMID: 12382160

10

Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.

Lutterotti A, Reindl M, Gassner C, Poustka K, Schanda K, Deisenhammer F, Berger T. Lutterotti A, et al. Among authors: deisenhammer f. J Neuroimmunol. 2002 Oct;131(1-2):201-7. doi: 10.1016/s0165-5728(02)00271-0. J Neuroimmunol. 2002. PMID: 12458053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters